HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Sette Selected Research

A Sette Research Topics

Disease

13Infections
01/2012 - 03/2000
6Neoplasms (Cancer)
05/2016 - 03/2000
4Melanoma (Melanoma, Malignant)
05/2016 - 01/2000
3Hypersensitivity (Allergy)
03/2016 - 12/2002
3Asthma (Bronchial Asthma)
01/2016 - 10/2015
3Malaria
02/2009 - 07/2000
2Rhinitis
01/2016 - 12/2015
2Carcinoma (Carcinomatosis)
03/2001 - 03/2000
1Cystic Fibrosis (Mucoviscidosis)
08/2015
1Arthritis (Polyarthritis)
05/2007
1Rheumatoid Arthritis
05/2007
1Reinfection
12/2005
1Schistosomiasis (Bilharziasis)
12/2005
1Dyspnea (Shortness of Breath)
06/2005
1Communicable Diseases (Infectious Diseases)
06/2002
1Hepatitis C
12/2001
1Chronic Hepatitis (Chronic Active Hepatitis)
12/2001
1Rheumatic Heart Disease (Rheumatic Heart Diseases)
09/2001
1Inflammation (Inflammations)
05/2001
1Virus Diseases (Viral Diseases)
03/2001
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2001
1Chronic Hepatitis C
03/2001
1Spondylarthropathies
03/2001
1Colorectal Neoplasms (Colorectal Cancer)
01/2001
1Disease Progression
08/2000
1HIV Infections (HIV Infection)
06/2000
1Human Influenza (Influenza)
05/2000

Drug/Important Bio-Agent (IBA)

17EpitopesIBA
02/2009 - 01/2000
15Peptides (Polypeptides)IBA
05/2007 - 01/2000
14VaccinesIBA
01/2012 - 06/2000
10AntigensIBA
05/2016 - 10/2000
4Proteins (Proteins, Gene)FDA Link
09/2001 - 03/2000
3AllergensIBA
03/2016 - 10/2015
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2005 - 01/2001
2AIDS VaccinesIBA
12/2001 - 08/2000
2HLA-A*02:01 antigenIBA
07/2001 - 03/2000
2HLA-A2 Antigen (HLA A2 Antigen)IBA
04/2001 - 05/2000
2CytokinesIBA
03/2001 - 07/2000
2HLA-A Antigens (HLA-A)IBA
10/2000 - 03/2000
2MART-1 AntigenIBA
10/2000 - 01/2000
1Cancer VaccinesIBA
05/2016
1HLA-DQ Antigens (HLA-DQ)IBA
08/2015
1SulfamethoxazoleFDA LinkGeneric
08/2015
1AutoantigensIBA
05/2007
1Aggrecans (Aggrecan)IBA
05/2007
1Histocompatibility Antigens Class IIIBA
05/2007
1TropomyosinIBA
12/2005
1Subunit VaccinesIBA
12/2005
1AsbestosIBA
06/2005
1Antimalarials (Antimalarial Agents)IBA
11/2003
1AntibodiesIBA
12/2002
1Neutralizing AntibodiesIBA
12/2001
1Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2001
1Viral AntigensIBA
09/2001
1HLA-B51 AntigenIBA
04/2001
1Interferon-gamma (Interferon, gamma)IBA
04/2001
1Histocompatibility Antigens Class IIBA
03/2001
1Arginine (L-Arginine)FDA Link
03/2001
1HLA-B27 Antigen (HLA B27 Antigen)IBA
03/2001
1Monophenol Monooxygenase (Tyrosinase)IBA
10/2000
1Combined VaccinesIBA
10/2000
1Dichlororibofuranosylbenzimidazole (DRB)IBA
08/2000
1HLA-DR Antigens (HLA-DR)IBA
03/2000
1Oncogene Proteins (Oncogene Protein)IBA
03/2000

Therapy/Procedure

5Immunotherapy
05/2016 - 06/2000
1Therapeutics
01/2012